12:00 AM
Feb 20, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bactramin regulatory update

Chugai submitted a regulatory application in Japan to expand the label of antibiotic Bactramin sulfamethoxazole/trimethoprim to include the prevention of Pneumocystis pneumonia infection. The synthetic...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >